-
Je něco špatně v tomto záznamu ?
Comparison of 3 Different Systems for Non-wire Localization of Lesions in Breast Cancer Surgery
L. Gabrielova, I. Selingerova, J. Zatecky, O. Zapletal, P. Burkon, M. Holanek, O. Coufal
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- lidé MeSH
- mikrochirurgie MeSH
- nádory prsu * diagnostické zobrazování chirurgie patologie MeSH
- prsy patologie MeSH
- segmentální mastektomie metody MeSH
- voda MeSH
- zaměřovací značky pro radioterapii MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: Localizing breast lesions by marking tumors and their detection using probes during surgery is a common part of clinical practice. Various nonwire localization systems were intended to be compared from different perspectives. METHODS: Various measurement experiments were performed. Localization techniques, including radioactive seed (RSLS), magnetically guided (MGLS), or radar (SLS), were compared in signal propagation in water and tissue environments, signal interference by surgical instruments, and the practical experience of surgeons. Individual experiments were thoroughly prospectively planned. RESULTS: The RSLS signal was detectable at the largest evaluated distance, ie, 60 mm. The SLS and MGLS signal detection was shorter, up to 25 mm to 45 mm and 30 mm, respectively. The signal intensity and the maximum detection distance in water differed slightly depending on the localization marker orientation to the probe, especially for SLS and MGLS. Signal propagation in the tissue was noted to a depth of 60 mm for RSLS, 50 mm for SLS, and 20 mm for MGLS. Except for the expected signal interferences by approaching surgical instruments from any direction for MGLS, the signal interruption for RSLS and SLS was observed only by inserting instruments directly between the localization marker and probe. Moreover, the SLS signal interference by instrument touch was noted. Based on surgeons' results, individual systems did not differ significantly for most measurement condition settings. CONCLUSION: Apparent differences noted among localization systems can help experts choose an appropriate system for a specific situation or reveal small nuances that have not yet been observed in clinical practice.
Department of Comprehensive Cancer Care Faculty of Medicine Masaryk University Brno Czech Republic
Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Mathematics and Statistics Faculty of Science Masaryk University Brno Czech Republic
Department of Pharmacology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Radiation Oncology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Radiation Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Surgery Silesian Hospital in Opava Opava Czech Republic
Department of Surgical Oncology Faculty of Medicine Masaryk University Brno Czech Republic
Research Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016717
- 003
- CZ-PrNML
- 005
- 20231026105615.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.clbc.2023.05.006 $2 doi
- 035 __
- $a (PubMed)37301711
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gabrielova, Lucie $u Department of Breast, Skin, and Oncoplastic Surgery, Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Surgical Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 10
- $a Comparison of 3 Different Systems for Non-wire Localization of Lesions in Breast Cancer Surgery / $c L. Gabrielova, I. Selingerova, J. Zatecky, O. Zapletal, P. Burkon, M. Holanek, O. Coufal
- 520 9_
- $a PURPOSE: Localizing breast lesions by marking tumors and their detection using probes during surgery is a common part of clinical practice. Various nonwire localization systems were intended to be compared from different perspectives. METHODS: Various measurement experiments were performed. Localization techniques, including radioactive seed (RSLS), magnetically guided (MGLS), or radar (SLS), were compared in signal propagation in water and tissue environments, signal interference by surgical instruments, and the practical experience of surgeons. Individual experiments were thoroughly prospectively planned. RESULTS: The RSLS signal was detectable at the largest evaluated distance, ie, 60 mm. The SLS and MGLS signal detection was shorter, up to 25 mm to 45 mm and 30 mm, respectively. The signal intensity and the maximum detection distance in water differed slightly depending on the localization marker orientation to the probe, especially for SLS and MGLS. Signal propagation in the tissue was noted to a depth of 60 mm for RSLS, 50 mm for SLS, and 20 mm for MGLS. Except for the expected signal interferences by approaching surgical instruments from any direction for MGLS, the signal interruption for RSLS and SLS was observed only by inserting instruments directly between the localization marker and probe. Moreover, the SLS signal interference by instrument touch was noted. Based on surgeons' results, individual systems did not differ significantly for most measurement condition settings. CONCLUSION: Apparent differences noted among localization systems can help experts choose an appropriate system for a specific situation or reveal small nuances that have not yet been observed in clinical practice.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a nádory prsu $x diagnostické zobrazování $x chirurgie $x patologie $7 D001943
- 650 _2
- $a prsy $x patologie $7 D001940
- 650 _2
- $a mikrochirurgie $7 D008866
- 650 _2
- $a zaměřovací značky pro radioterapii $7 D057918
- 650 _2
- $a voda $7 D014867
- 650 _2
- $a segmentální mastektomie $x metody $7 D015412
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Selingerova, Iveta $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: iveta.selingerova@mou.cz
- 700 1_
- $a Zatecky, Jan $u Department of Breast, Skin, and Oncoplastic Surgery, Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Surgery, Silesian Hospital in Opava, Opava, Czech Republic; The Institute of Paramedical Health Studies, Faculty of Public Policies, Silesian University, Opava, Czech Republic
- 700 1_
- $a Zapletal, Ondrej $u Department of Breast, Skin, and Oncoplastic Surgery, Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Surgical Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Burkon, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Holanek, Milos $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Coufal, Oldrich $u Department of Breast, Skin, and Oncoplastic Surgery, Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Surgical Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00188740 $t Clinical breast cancer $x 1938-0666 $g Roč. 23, č. 6 (2023), s. e323-e330
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37301711 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105610 $b ABA008
- 999 __
- $a ok $b bmc $g 2000310 $s 1203079
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 23 $c 6 $d e323-e330 $e 20230518 $i 1938-0666 $m Clinical breast cancer $n Clin Breast Cancer $x MED00188740
- LZP __
- $a Pubmed-20231013